Intercept Pharma Danmark ApS: Financial statements 2018
CVR: 37104469
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Intercept Pharma Danmark ApS (CVR 37104469) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,052,615 and a net result of DKK -7,148,070 compared with DKK -25,789,009 the year before. Equity in the 2018 report amounted to DKK -38,866,748. The company had 5 employees in the financial year.
- Gross Profit
- DKK 1,052,615
- Profit/Loss
- DKK -7,148,070
- Equity
- DKK -38,866,748
- Total Assets
- DKK 8,425,357
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.1 mio. | -7.1 mio. | -38.9 mio. | 5 |
| 2017 | - | -9.2 mio. | -25.8 mio. | -31.7 mio. | 5 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Intercept Pharma Danmark ApS has published its annual report for 2017. Gross profit came to DKK -9,176,767, and the net result was DKK -25,789,009.
As of January 11, 2018, Daniel Hood is registered as director of Intercept Pharma Danmark ApS.
About Intercept Pharma Danmark ApS
Intercept Pharma Danmark ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2015 and dissolved in 2020. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 2,803,867 and a net result of DKK -27,225 compared with DKK -7,148,070 the year before. Equity in the 2019 report amounted to DKK -38,893,973.